Playing from staycurrentmd
11 views 0 likes

StayCurrentMD

GCMD Space · View profile →

Current management of pulmonary relapse in Ewing sarcoma: A report from the Pediatric Surgical Oncology Research Collaborative

Video Published 2025-12-22 Updated 2026-08-01

Timestops (3)

Topic Overview

A 74-second research summary of a 2024 multi-center retrospective study by Writer et al. examining pulmonary relapse patterns in pediatric Ewing sarcoma. The study found that patients with solitary pulmonary nodule relapse had significantly better 3-year survival (73%) compared to those with multiple nodules (40%) or extrapulmonary disease (23%), suggesting solitary pulmonary relapse may represent a biologically favorable recurrence amenable to local control with metastasectomy as part of multimodal therapy.

Key Takeaways

  • Solitary pulmonary nodule relapse in Ewing sarcoma has 73% 3-year survival vs 40% for multiple nodules. (0:39)
  • Metastasectomy is key in multimodal therapy for solitary pulmonary relapse in Ewing sarcoma. (0:57)
  • Solitary pulmonary relapse may represent biologically favorable recurrence amenable to local control. (0:57)
  • Extrapulmonary disease at relapse has poorest prognosis with only 23% 3-year survival. (0:50)

Inside this episode

Kai, the Library's AI content creator, listened to this episode and mapped who's speaking, the chapters, key claims, and cases. Every item links to the exact moment in the recording.

AI-enriched

Who's speaking

  • Sovia Skermerhorn — guest

Chapters

  • 0:00Study Background and Design — Introduction of the PeaceSOC multi-center retrospective study examining pulmonary relapse in pediatric Ewing sarcoma patients across 19 centers from 2007-2020.
  • 0:32Key Findings on Relapse Patterns and Survival — Presentation of survival outcomes stratified by relapse pattern: solitary nodule (73% 3-year survival), multiple nodules (40%), and extrapulmonary disease (23%).
  • 0:55Clinical Implications — Discussion of the biological and therapeutic significance of solitary pulmonary relapse and the role of metastasectomy in multimodal treatment.

Key claims

  • 0:05Writer et al. published a multi-center retrospective study in the Journal of Pediatric Surgery through PeaceSOC in 2024 — Sovia Skermerhorn
  • 0:07PeaceSOC is a network of over 50 centers in North America that work together to improve outcomes in pediatric surgical oncology — Sovia Skermerhorn
  • 0:20The study examined patients less than 22 years old with initially localized Ewing sarcoma who developed first pulmonary relapse between 2007 and 2020 across 19 different centers — Sovia Skermerhorn
  • 0:32Among 33 patients studied, about 2/3 had relapse limited to the lungs — Sovia Skermerhorn
  • 0:32Nearly half of patients with lung-limited relapse had just a solitary pulmonary nodule — Sovia Skermerhorn
  • 0:39Patients with solitary pulmonary nodule were more likely to undergo metastasectomy and whole lung radiation — Sovia Skermerhorn
  • 0:39Patients with solitary pulmonary nodule had the highest overall three-year survival at 73% — Sovia Skermerhorn
  • 0:50Three-year survival for patients with multiple nodules was 40% — Sovia Skermerhorn
  • 0:50Three-year survival for patients with extrapulmonary disease was 23% — Sovia Skermerhorn
  • 0:57Solitary pulmonary relapse may represent a biologically more favorable type of recurrence — Sovia Skermerhorn
  • 0:57Solitary pulmonary relapse is more amenable to achieving meaningful local control — Sovia Skermerhorn
  • 0:57Metastasectomy plays an important role as part of multimodal therapy for solitary pulmonary relapse in Ewing sarcoma — Sovia Skermerhorn

Open questions

  • Would you offer a metastasectomy for a solitary Ewing relapse at your institution?
This episode was analyzed and enriched by Kai, the Library's AI content creator. Every item links to the moment it comes from — click a timestamp to listen in context.

Keywords

Hashtags

Transcript

Comments

Loading comments…